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Various forms of carcinogenesis of melanoma have been pro-
posed.1 Among them, Wang and DuBois1 reported that chronic
inﬂammation could generate an immunosuppressive microenvi-
ronment favorable to tumor formation and progression.
In this report, we describe a case of acral lentigenous melanoma
(ALM) developing in the lesional skin of bullous congenital ichthyo-
siform erythroderma (BCIE).
A 43-year-old Japanese woman visited our outpatient clinic with
a 3-year history of a black plaque on her dorsal hand. She had been
diagnosedwith BCIE soon after birth. On her initial visit, physical ex-
amination revealed anasymmetric blackmacule on thedorsal side of
her left hand (Figure 1A). Dermoscopy revealed an atypical reticular
pattern, asymmetric globules and dots, irregular streaks and blue-
ewhite veil. According to dermoscopy ﬁndings, we treated this pa-
tient as having acral lentigenous melanoma (ALM) and excised the
tumorwith a 10-mmmargin.Histologicalﬁndings showedmarkedly
atypicalmelanocytes arranged in irregular nests and solitary units at
all levels of the epidermis to upper dermis (Figure 1B). Tumor thick-
nesswas 1.0mm. From the above ﬁndings, we diagnosed this patientFigure 1 (A) Asymmetric black macule on the dorsal side of the left hand. (B) Tumor area: m
of the epidermis to upper dermis. (C) Marginal area of the tumor: hyperkeratosis, acanthos
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creativecommons.org/licenses/by-nc-nd/4.0/).having ALM (pT1aN0M0 Stage IA). At themarginal area of the tumor,
histological ﬁndings revealed hyperkeratosis, acanthosis, and gran-
ular degeneration in the epidermis (Figure 1C). Immunohistochem-
ical staining revealed that these atypical melanocytes were positive
for Melan A, HMB45, and programmed death ligand (PD-L)1
(Figure 2A), and surrounded by Foxp3þ regulatory T (Treg) cells
(Figure 2C). In addition, at the marginal area of the tumor, keratino-
cytes in the stratum spinosum expressed PD-L1 (Figure 2B) and
Foxp3þ Treg cellswere scattered in the area adjacent to thebasement
membrane (Figure 2D). We screened for possible internal malig-
nancy by positron emission tomographyecomputed tomography
and found no evidence of metastasis.
BCIE is a dominantly inherited ichthyosis, frequently associated
withmutations in keratin 1 or keratin 10 that result in disruption of
the keratin ﬁlament cytoskeleton, leading to keratinocyte fragility.2
Although BCIE patients typically display an abnormality in the
permeability barrier function, and histological ﬁndings suggest
chronic skin inﬂammation, little is known about the immunological
background of BCIE.2
Since the expression of PD-L1 on cancer cells is reported to
determine the prognosis in various types of cancer includingarkedly atypical melanocytes arranged in irregular nests and solitary units in all levels
is and granular degeneration in the epidermis.
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Figure 2 Parafﬁn-embedded tissue samples were deparafﬁnized and stained with (A,B,E) anti-PD-L1 antibody and (C,D) anti-Foxp3 antibody. (AeE) The sections were developed
with liquid permanent red. (A,C: tumor area, B,D: marginal area of the tumor, E: normal skin) (Original magniﬁcation: A,B, 200; C,D, 400). At the tumor site, (A) atypical me-
lanocytes expressed PD-L1, and were surrounded by (C) Foxp3þ Treg cells. At the marginal area of the tumor, (B) keratinocytes in the stratum spinosum expressed PD-L1, and (D)
Foxp3þ Treg cells were scattered in the area adjacent to the basement membrane. (E) Normal keratinocytes expressed PD-L1. Foxp3 ¼ forkhead boxP3; PD-L1 ¼ programmed death
ligand 1; Treg cell ¼ T regulatory cell.
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evaluating the malignancy. Concerning the normal skin, previous
reports suggested that chronic skin inﬂammation induced PD-L1
on keratinocytes, leading the carcinogenesis of the skin.3 Indeed,
another report also suggested a correlation between chronic skin
inﬂammation and carcinogenesis of the skin in inherited ichthyo-
ses.4 Concerning our present case, keratinocytes in the stratum spi-
nosum strongly expressed PD-L1 in the marginal area of the tumor.
Since PD-L1 promotes both the induction and maintenance of Treg
cells,5 chronic inﬂammation in BCIE might maintain the immuno-
suppressive microenvironment in concert with Treg cells.
Treg cells play a pivotal role in maintaining peripheral toler-
ance.5,6 In the tumor site, Treg cells maintain the immunosuppres-
sive microenvironment and promote tumor growth.6 Notably, a
recent report suggested that one of the possible anti-tumor effects
of immunocheck point inhibitor, ipilimumab, is the depletion of
Treg cells in the tumor site.7 These reports suggested that Treg cells
in the tumor site could be one of the prognostic factors for mela-
noma patients, and that depletion of Treg cells could be an optimal
supportive therapy for humanmelanoma. Notably, compared to the
normal skin, substantial numbers of Treg cells were detected in
various skin inﬂammatory diseases such as psoriasis and atopic
dermatitis.8 These reports suggested that the long-term, continuous
skin inﬂammation caused by BCIE might have promoted the devel-
opment of melanoma in our case. Although this is the ﬁrst English-
language report of ALM accompanied by BCIE, we could not rule out
the possibility of coincidence of ALMand BCIE. Therefore, to conﬁrm
our hypothesis, further cases and studies will be necessary.Yusuke Muto, Taku Fujimura*, Aya Kakizaki, Hisayuki Tono,
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